Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
TEBio-Techne Corporation logo

Bio-Techne Corporation (TECH)

NASDAQ · Currency in USD
$72.55 ▼ -0.07 (-0.10%)
At close: Oct 23, 4:00 PM ET. Market closed.
$72.64 ▲ +0.09 (+0.12%)
After hours: Oct 23, 7:52 PM ET

Summary

Previous Close
$72.62
Open
$72.60
Day's Range
$72.55 – $72.63
52 Week Range
$43.20 – $72.69
Volume
1,898,228
Avg. Volume
4,222,744
Market Cap
$11.38B
Beta (5Y Monthly)
1.30
PE Ratio (TTM)
62.01
EPS (TTM)
$1.17
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$0.32 (0.44%)
Ex-Dividend Date
Aug 24, 2026
1y Target Est
$65.78

Profile: Bio-Techne Corporation

Sector
Healthcare
Industry
Biotechnology
Full-time employees
3,000
CEO
Kim Kelderman

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.44 · Revenue est. $292.60M
DateEst.Actual
Aug 12, 2026$0.52$0.52Beat
May 6, 2026$0.55$0.53Miss
Feb 4, 2026$0.43$0.46Beat
Nov 5, 2025$0.42$0.42Miss
Aug 6, 2025$0.50$0.53Beat
May 7, 2025$0.51$0.56Beat

Analyst view

Consensus price target
$65.78 ▼ -9.3%
Range $50.00 – $73.00
Rating: Hold
Buy 46% · Hold 54% · Sell 0%

Get free alerts on TECH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.